Neovantage Bio-Technology Private Limited
About Neovantage Bio-Technology Private Limited
Data last updated:
Neovantage Bio-Technology Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Lc Core Opportunities Fund Pte. Ltd.. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the real estate financing segment of the financial services sector. It was incorporated on 09 July 2016.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC110776. Its GSTIN is 36AAKCM4430F1ZL (Telangana).
The company had an authorised share capital of ₹12.5 Cr and a paid-up capital of ₹9.82 Cr. It was led by directors Shilpi Chowdhary and Chandan Kumar Mishra.
Its last annual general meeting (AGM) was held on 26 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Building – 450 Genome Valley Turkapally (V) Shamirpet Mandal, Hyderabad, Telangana, India – 500078.
As per the financials filed for FY 2024, the company reported a revenue of ₹35.52 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net loss of ₹1.37 Cr (net margin -3.9%) and EBITDA of ₹11.98 Cr (EBITDA margin 33.7%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 16% over five years.
Its group structure included 1 subsidiary.
As per MCA filings, the company had open charges of ₹63 Cr and satisfied charges of ₹361.6 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 convertible or debt financing), with disclosed funding of ₹2.98 Cr; the latest was in October 2021.
Company details
Contact details
Neovantage Bio-Technology Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding – 450 Genome Valley Turkapally (V) Shamirpet Mandal, Hyderabad, Telangana, India – 500078
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Neovantage Bio-Technology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neovantage Bio-Technology is real estate. In detail, this covers real estate activities on fee or contract basis.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L2 | Real estate activities on fee or contract basis |
To see the full business activity and turnover split of Neovantage Bio-Technology Private Limited, buy the company report.
Financials of Neovantage Bio-Technology Private Limited
FY 2024 filings availableNeovantage Bio-Technology Private Limited reported revenue of ₹35.52 Cr (up 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 14% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.7% | ||||
| Net Profit Margin | -3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neovantage Bio-Technology Private Limited, buy the company report.
Board of directors of Neovantage Bio-Technology Private Limited
Neovantage Bio-Technology has 2 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpi Chowdhary | Director | 10 Jul 2018 | 8 Years 4 Months | As last reported |
| Chandan Kumar Mishra Also directs: LC Nueva Investment Partners LLP, LC Investment Advisors LLP, LC Alternatives Advisors (India) LLP and 4 more | Additional Director | 17 Oct 2024 | 2 Years 0 Months | As last reported |
Auditor
Neovantage Bio-Technology Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2021 | 012754N/N500016 |
Shareholding
The shareholding of Neovantage Bio-Technology Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Neovantage Bio-Technology Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Dec 2019 | 100314853 | Others | ₹69.6 Cr | Satisfied | |
| 07 Sep 2018 | 100203201 | Others | ₹70 Cr | Satisfied | |
| 27 Sep 2016 | 100058218 | Idbi Trusteeship Services Limited | ₹54.5 Cr | Satisfied | |
| 27 Sep 2016 | 100060738 | Idbi Trusteeship Services Limited | ₹167.5 Cr | Satisfied |
To see the full charge records of Neovantage Bio-Technology Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Neovantage Bio-Technology Private Limited has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 convertible or debt financing), with disclosed funding of ₹2.98 Cr; the latest was in October 2021.
Deals on record (3 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Acquisition | ₹12.46 Cr | Buyer: Lighthouse Canton |
| Sep 2016 | Acquisition | ₹4.15 Cr | Buyer: Lighthouse Canton |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: Canton Real Estate Investments Pte Limited Seller: 2 individuals |
To see the full deal history of Neovantage Bio-Technology Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Neovantage Bio-Technology Private Limited has 1 court case on record: 1 filed by Neovantage Bio-Technology. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Neovantage Bio-Technology Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Neovantage Bio-Technology Private Limited was last rated by Care on 07 Apr 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Apr 2022 |
To see the full credit ratings and regulatory alerts of Neovantage Bio-Technology Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neovantage Bio-Technology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Neovantage Bio-Technology has 1 subsidiary company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| MN Science & Technology Park Private Limited | U01119TG2001PTC037768 |
To see the full group structure of Neovantage Bio-Technology Private Limited, buy the company report.
GST
Neovantage Bio-Technology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCM4430F1ZL | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Neovantage Bio-Technology Private Limited, buy the company report.
Recent activity
Neovantage Bio-Technology Private Limited has 15 board changes on record since 2016: 2 appointments and 13 cessations. The latest: Chandan Kumar Mishra was appointed as Additional Director on 17 Oct 2024.
16 earlier events are in the company report.
Frequently asked questions
Neovantage Bio-Technology has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Neovantage Bio-Technology was a private limited company based in Hyderabad, Telangana, India. The company worked in real estate financing, within the financial services industry. It was incorporated on 09 July 2016 and is registered under CIN U74999TG2016PTC110776. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Neovantage Bio-Technology was incorporated on 09 July 2016. It is registered with the Registrar of Companies, Hyderabad.
Neovantage Bio-Technology had 2 directors:
- Shilpi Chowdhary - Director
- Chandan Kumar Mishra - Additional Director
The CIN (Corporate Identification Number) of Neovantage Bio-Technology is U74999TG2016PTC110776. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Neovantage Bio-Technology is at Building – 450 Genome Valley Turkapally V Shamirpet Mandal, Hyderabad, Telangana, India – 500078.
The latest financial statements of Neovantage Bio-Technology on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 26 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Neovantage Bio-Technology is 36AAKCM4430F1ZL, registered in Telangana.
Neovantage Bio-Technology operated in the financial services industry, in the real estate financing segment.
Neovantage Bio-Technology has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 convertible or debt financing), with disclosed funding of ₹2.98 Cr; the latest was in October 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
